Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging

by Hagen Kulbe, Oliver Klein, Zhiyang Wu, Eliane T. Taube, Wanja Kassuhn, David Horst, Silvia Darb-Esfahani, Paul Jank, Salem Abobaker, Frauke Ringel, Andreas du Bois, Florian Heitz, Jalid Sehouli, Elena I. Braicu
Published 2020-07-01

MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.

by Paul Jank, Claire Gehlhaar, Lederer Bianca, Fontanella Caterina, Schneeweiss Andreas, Thomas Karn, Frederik Marmé, Hans-Peter Sinn, Marion van Mackelenbergh, Bruno Sinn, Dirk-Michael Zahm, Barbara Ingold-Heppner, Christian Schem, Elmar Stickeler, Peter A Fasching, Valentina Nekljudova, Eliane Tabea Taube, Frank Heppner, Volkmar Müller, Carsten Denkert, Sibylle Loibl
Published 2020-01-01

Reproducibility of mRNA-Based Testing of <i>ESR1</i>, <i>PGR</i>, <i>ERBB2</i>, and <i>MKI67</i> Expression in Invasive Breast Cancer—A Europe-Wide External Quality Assessment

by Ramona Erber, Arndt Hartmann, Peter Andreas Fasching, Matthias Ruebner, Robert Stöhr, Matthias Wilhelm Beckmann, Miriam Zentgraf, Verena Popp, Jodi Weidler, Iris Simon, Steffi Becker, Hanna Huebner, Josephine Fischer, Elena Guerini Rocco, Giuseppe Viale, Anne Cayre, Frederique Penault-Llorca, Tamara Caniego Casas, Belén Pérez-Miés, José Palacios, Paul Jank, Carsten Denkert, Lina Khoury, Thomas Mairinger, Fulvia Ferrazzi
Published 2021-09-01